Review
Inhalation provocation tests using nonisotonic aerosols

https://doi.org/10.1016/0091-6749(89)90309-6Get rights and content

Abstract

The measurement of bronchial hyperresponsiveness with inhaled aerosols is now accepted as an objective measurement of the severity of asthma. The most commonly used agents administered as aerosols are methacholine and histamine, which are believed to cause airways to narrow by contracting bronchial smooth muscle via specific receptors. Patients with asthma may also have an attack provoked by inhaling aerosols that increase or decrease the osmolarity of the fluid lining the airways. There is evidence to suggest that a change in the osmolarity of the airways causes the release of mediators from inflammatory cells in the airways. Thus, inhalational challenge with nonisotonic aerosols, such as water and hyperosmolar saline, may be useful to assess bronchial hyperresponsiveness to endogenously released mediators. Described in this article are some of the techniques used to challenge with nonisotonic aerosols, and airway responses are discussed in relation to responses obtained with other bronchial provocation tests. The mechanisms whereby these aerosols cause airways to narrow are considered, and the clinical implications of identifying responsiveness to these aerosols are discussed. Specific recommendations are made with respect to equipment, technique, and choice of aerosol.

References (74)

  • SD Anderson

    Issues in exercise-induced asthma

    J Allergy Clin Immunol

    (1985)
  • JA Rankin et al.

    Bronchoalveolar lavage; its safety in subjects with mild asthma

    Chest

    (1984)
  • JDK Burton

    Effects of dry anaesthetic gases on the respiratory mucous membrane

    Lancet

    (1962)
  • JT Taguchi

    Effect of ultrasonic nebulization on blood gas tensions in chronic obstructive lung disease

    Chest

    (1971)
  • DW Cockcroft et al.

    Bronchial reactivity to inhaled histamine: a method and clinical survey

    Clin Allergy

    (1977)
  • K Yan et al.

    Rapid method tor measurement of bronchial responsiveness

    Thorax

    (1983)
  • EF Juniper et al.

    Reproducibility and comparison of responses to inhaled histamine and methacholine

    Thorax

    (1978)
  • D Hariparsad et al.

    Reproducibility of histamine challenge tests in asthmatic children

    Thorax

    (1983)
  • WJ Britton et al.

    Prevalence of bronchial hyperresponsiveness in children: the relationship between asthma and skin reactivity to allergens in two communities

    Int J Epidemiol

    (1986)
  • L Allegra et al.

    Non-specific broncho-reactivity obtained with ar ultrasonic aerosol of distilled water

    Eur J Respir Dis

    (1980)
  • RE Schoeffel et al.

    Bronchial hyperreactivity in response to inhalation of ultrasonically nebulised solutions of distilled water and saline

    Br Med J

    (1981)
  • P Magyar et al.

    Bronchial challenge with hypertonic KCl solution in the diagnosis of bronchial asthma

    Schweiz Med Wochenschr

    (1984)
  • SD Anderson

    Bronchial challenge by ultrasonically nebulized aerosols

    Clin Rev Allergy

    (1985)
  • WL Eschenbacher et al.

    Respiratory heat loss is not the sole stimulus for bronchoconstriction induced by isocapnic hyperpnea with dry air

    Am Rev Respir Dis

    (1985)
  • SD Anderson et al.

    Arterial plasma histamine levels at rest, during, and after exercise in patients with asthma: effects of terbutaline aerosol

    Thorax

    (1981)
  • TH Lee et al.

    Identification and partial characterization of an exercise-induced neutrophil chemotactic factor in bronchial asthma

    J Clin Invest

    (1982)
  • PA Eggleston et al.

    Interaction between hyperosmolar and IgE mediated histamine release from basophils and mast cells

    Am Rev Respir Dis

    (1984)
  • RJ Shaw et al.

    Mediators of hypersensitivity and “fog”-induced asthma

    Allergy

    (1985)
  • NG Belcher et al.

    A comparison of mediator and catecholamine release between exercise- and hypertonic saline-induced asthma

    Am Rev Respir Dis

    (1988)
  • TR Gravelyn et al.

    Mediator release in an isolated airway segment in subjects with asthma

    Am Rev Respir

    (1988)
  • G Silber et al.

    In vivo release of inflammatory mediators by hyperosmolar solutions

    Am Rev Respir Dis

    (1988)
  • J Wolsdorf et al.

    Mist therapy reconsidered: an evaluation of the respiratory deposition of labelled water aerosols produced by jet and ultrasonic nebulizers

    Paediatrics

    (1969)
  • RMG Boucher et al.

    The fundamentals of ultrasonic atomization of medical solutions

    Ann Allergy

    (1968)
  • SD Anderson et al.

    Evaluation of ultrasonically nebulised solutions for provocation testing in patients with asthma

    Thorax

    (1983)
  • RF Goddard et al.

    Output characteristics and clinical efficacy of ultrasonic nebulizers

    J Asthma Res

    (1963)
  • Cited by (93)

    • Post-inhalation cough with therapeutic aerosols: Formulation considerations

      2020, Advanced Drug Delivery Reviews
      Citation Excerpt :

      These pharmacologic agents act on airway smooth muscle receptors to induce bronchoconstriction. The recognition that most asthma patients are sensitive to osmotic stimuli has led to the development of alternative challenge agents, including inhaled hypertonic saline and inhaled mannitol (dry powder) [61]. Changes in osmolality may alter the ion composition of periciliary fluid, thereby activating release of substances (e.g., prostaglandins and leukotrienes) that induce smooth muscle contraction, inflammation, and increases in cell permeability via alteration of the structure of epithelial tight junctions [62].

    • Repurposing excipients as active inhalation agents: The mannitol story

      2018, Advanced Drug Delivery Reviews
      Citation Excerpt :

      Our interest became focussed on using hyperosmolar aerosols to identify bronchial hyperresponsiveness in subjects with known asthma. We compared responses to hyperosmolar aerosols of saline and hyperpnea of dry air [5–7] and found a good relationship between sensitivity to both challenges Fig. 1 [6,8]. A detailed protocol for BPT using 4.5% saline was published in 1989 [5].

    • Role of selective blocking of bradykinin receptor subtypes in attenuating allergic airway inflammation in guinea pigs

      2016, European Journal of Pharmacology
      Citation Excerpt :

      However, the latter did show a milder degree of airway reactivity. The reasons behind this finding might be attributed to changes in the fluid lining of the respiratory tract upon saline challenge or that animals started to develop chronic allergic pulmonary inflammation (Smith and Anderson, 1989; Souza et al., 2013). A putative role of bradykinin B1 receptors in allergic inflammation is supported by the results of this research.

    • Assessment of EIB. What You Need to Know to Optimize Test Results.

      2013, Immunology and Allergy Clinics of North America
      Citation Excerpt :

      Hyperosmolar saline was developed as a bronchial provocation test during the 1980s. When it was observed that patients with asthma with EIB could have an attack of asthma provoked by inhaling hyperosmolar aerosols,81 the tests were standardized and became used as surrogates for exercise.82,83 However, there were limitations in that a large-volume ultrasonic nebulizer was needed, and the dose of the aerosol delivered could differ widely between patients and over time, depending on the inspiratory flow through the nebulizer and the age of the piezoelectric crystal.84

    • Indirect challenge tests: Airway hyperresponsiveness in asthma: Its measurement and clinical significance

      2010, Chest
      Citation Excerpt :

      The hypertonic (4.5%) saline test was developed to investigate the hypothesis that EIB was caused by a transient increase in osmolarity of the airway surface liquid as a consequence of humidifying large volumes of air during exercise.21 The aerosol is generated using a high-output ultrasonic nebulizer and delivered for progressively increasing intervals (0.5, 1, 2, 4, 8 min).22 A positive response, originally defined as a 20% fall in FEV1, was reduced to 15% after large numbers of healthy subjects had been studied.

    View all citing articles on Scopus
    View full text